Ranking Profile - Apellis Pharmaceuticals Inc


Apellis Pharmaceuticals Inc (Apellis) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases through inhibition of the complement system at the level of C3 (central protein). Its pipeline product portfolio includes EMPAVELI pegcetacoplan injection for paroxysmal nocturnal hemoglobinuria disease and SYFOVRE intravitreal pegcetacoplan injection for Geographic Atrophy. Its other products include APL-1030, APL-2006 and Orala Alternative Pathway Inhibitor, among others. The company conducts research on chronic therapy with a C3 inhibitor into clinical trialsIt operates in Australia, Bermuda, the US, Germany, France, Ireland, the Netherlands, Switzerland, the UK nad Cayman Islands. Apellis is headquartered in Waltham, Massachusetts, the US.

Company info

Country (HQ): United States
Sector: Pharmaceuticals and Healthcare
Market Cap (US$ m): 10,394
Revenue (US$ m): 75 (2022)

Innovation ranking


Innovation score

Closest peers in the Pharmaceuticals and Healthcare sector

Innovation Ranking


Johnson & Johnson

United States

Pharmaceuticals and Healthcare

F. Hoffmann-La Roche Ltd


Pharmaceuticals and Healthcare

Apellis Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

EyeGate Pharmaceuticals Inc

United States

Pharmaceuticals and Healthcare

Shin Poong Pharm Co Ltd

South Korea

Pharmaceuticals and Healthcare

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers